Home > Non-prescription medicinal products containing codeine: guidance for pharmacists on safe supply to patients.

Pharmaceutical Society of Ireland. (2019) Non-prescription medicinal products containing codeine: guidance for pharmacists on safe supply to patients. Dublin: PSI.

[img]
Preview
PDF (Non-prescription medicinal products containing codeine)
476kB

The overall purpose of this guidance is to improve patient safety in the use of non-prescription medicinal products containing codeine (hereafter called ‘codeine medicine’) by ensuring the safe supply of codeine medicines by pharmacists. This guidance is intended to assist pharmacists in meeting their legal and professional responsibilities when supplying these medicines to patients and when providing advice, guidance and assistance in respect of the use of these medicines. It is also intended to assist superintendent and supervising pharmacists in securing compliance with relevant legislative and professional obligations under the Pharmacy Act 2007, including the Regulation of Retail Pharmacy Businesses Regulations 2008 (S.I. No. 488 of 2008).


Date:April 2019
Pages:8 p.
Publisher:PSI
Corporate Creators:Pharmaceutical Society of Ireland
Place of Publication:Dublin
Edition:Version 4
EndNote:View
Subjects:B Substances > Opioids (opiates) > Opioid product
B Substances > Opioids (opiates) > Opioid product > Codeine
E Concepts in biomedical areas > Substance by legal status > Over the counter drug (medicine / medication)
J Health care, prevention and rehabilitation > Substance use prevention > Substance use harm reduction
N Communication, information and education > Recommendations or guidelines > Practice / clinical guidelines
T Demographic characteristics > Pharmacist
VA Geographic area > Europe > Ireland

Repository Staff Only: item control page